1. Phase II study of single-agent therapy with megestrol acetate, VP-16-231, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer;Hahn;Cancer Treat Rep,1979
2. Lomustine treatment of metastatic renal coll carcinoma;Mittelman;JAMA,1973
3. Phase II evaluation of chlorozotocin in patients with renal cell carcinoma;Gralla;Cancer Treat Rep,1979
4. Effects of 5-fluorouracil (NSC-19893) in 389 patients with cancer;Moore;Cancer Chemother Rep,1968
5. Phase II evaluation of adriamycin in human neoplasia;O’Bryan;Cancer,1973